logo
#

Latest news with #nonHodgkinsLymphoma

Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284
Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284

Globe and Mail

time10 hours ago

  • Business
  • Globe and Mail

Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284

Lantern Pharma (NASDAQ: LTRN) announced the European Patent Office has issued a notice of allowance for a composition of matter patent covering LP-284, a clinical-stage drug candidate for relapsed or refractory non-Hodgkin's lymphoma. The patent, expected to grant with exclusivity through 2039, adds to existing IP in the U.S. and Japan and supports global commercialization efforts. LP-284, developed using Lantern's RADR(R) AI platform, is in Phase 1 trials and holds Orphan Drug Designations for MCL and HGBL. The drug targets a $4 billion global market, and its rapid development timeline and cost efficiency bolster Lantern's strategic partnership potential. To view the full press release, visit About Lantern Pharma Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. The company's proprietary AI and machine learning platform, RADR(R), leverages over 200 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, Lantern has accelerated the development of its growing pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers. On average, Lantern's newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $2.5 million per program. NOTE TO INVESTORS: The latest news and updates relating to LTRN are available in the company's newsroom at About BioMedWire BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text 'Biotech' to 888-902-4192 (U.S. Mobile Phones Only) For more information please visit Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

Somerset couple chase bucket list dreams amid health scares
Somerset couple chase bucket list dreams amid health scares

BBC News

time29-06-2025

  • BBC News

Somerset couple chase bucket list dreams amid health scares

A married couple say two major health scares gave them the push they needed to "live life to the fullest" and tick off every bucket list bloggers Hannah Bird and Charlie Camper, from Burnham-on-Sea in Somerset, have explored more than 50 countries together over the past six years. Mr Camper wears an implanted defibrillator after suffering a cardiac arrest at the age of 15, while Ms Bird was diagnosed with stage 4 blood cancer in 25-year-olds have amassed an online following of more than 450,000 people, and use their platform to share travel tips and raise awareness of symptoms. For six months, doctors told Ms Bird her persistent cough, night sweats, constant exhaustion and unexplained bruising were nothing to worry about. But a week after the couple's engagement, she was officially diagnosed with non-Hodgkin's lymphoma diagnosis - an aggressive cancer that affects white blood cells. Throughout 18 gruelling rounds of chemotherapy and immunotherapy, the couple sat together in hospital and planned their adventures. "Every appointment we'd sit there and think 'where do we want to go? What do we want to see?' It was the one thing really pushing us through," said Ms Bird. With doctors so "unsure about what the future was going to hold", the couple took a chance and booked a last-minute flight to Cappadocia in day after they returned from their spontaneous trip, a PET scan revealed there were no more cancer cells left in Ms Bird's body. "We gained quite a good following off the back of that trip," the couple said."People were asking us how we do it, saying we were quite inspirational, which made us blush a lot. "We started blogging more and it kind of escalated from there." Their passports are now adorned with stamps from across the world - including Tokyo, Australia, Singapore, Greece, Switzerland, Budapest, Egypt, Kenya, Dubai, Iceland, and Norway. "We've got a big bucket list on a bit of paper in our bedroom, but it seems to constantly get longer and longer," Ms Bird laughed."I don't think its ever going to stop if I'm honest, we see new inspiration pretty much every day."The couple have now been shortlisted for the ITV Travel Creator of the Year award in recognition of their engaging content and inspiring stories.

After cancer diagnosis at 35 and rapid weight gain, survivor fights to claim first Ironman
After cancer diagnosis at 35 and rapid weight gain, survivor fights to claim first Ironman

South China Morning Post

time10-06-2025

  • Health
  • South China Morning Post

After cancer diagnosis at 35 and rapid weight gain, survivor fights to claim first Ironman

A month after his 35th birthday, Nidhin Valsan received unwelcome news: a diagnosis of late-stage non-Hodgkin's lymphoma, a type of blood cancer. Advertisement The senior officer with the Indian Police System was shaken, but he steeled himself for the fight of his life. He would undergo gruelling treatment – and afterwards, train to complete his first triathlon: the Ironman 70.3 Goa. He chronicles his return to wellness in his memoir Cancerman to Ironman: A Police Officer's Journey of Arresting Illness. It describes his battle with cancer, the support system that sustained him, his struggle with anxiety and depression, and training for the Ironman. Valsan with his wife Remya and two children after finishing the Ironman 70.3 Goa in 2022. Photo: Nidhin Valsan In 2020, Valsan had been posted to India's Goa state as superintendent of police. Soon after, he began getting chest pains and developed pain in his groin. Advertisement 'I would wake up in the middle of the night in agony. I was barely getting sleep and lost 4kg [8.8lb] within a month,' says the now 39-year-old, adding that he was in excruciating pain for three months.

EXCLUSIVE 'It changed the trajectory of my life': Singer Delta Goodrem, 40, discusses shock teenage cancer diagnosis and losing her voice at 30 on new Mail podcast
EXCLUSIVE 'It changed the trajectory of my life': Singer Delta Goodrem, 40, discusses shock teenage cancer diagnosis and losing her voice at 30 on new Mail podcast

Daily Mail​

time09-06-2025

  • Entertainment
  • Daily Mail​

EXCLUSIVE 'It changed the trajectory of my life': Singer Delta Goodrem, 40, discusses shock teenage cancer diagnosis and losing her voice at 30 on new Mail podcast

Podcast All episodes From a shock teenage cancer diagnosis to having to relearn how to speak at 30, Australian singer Delta Goodrem discussed the health battles that transformed her career on the latest episode of the Mail's Life of Bryony podcast. Delta, 40, is one of Australia's most decorated female singer-songwriters. The former partner of Westlife singer Brian McFadden signed her first recording contract at only 15 years old and her 2003 debut album 'Innocent Eyes' topped charts for 29 weeks. Before embarking on her first world tour at 18, Delta was diagnosed with non-Hodgkin's lymphoma, an aggressive type of blood cancer. During her time battling the disease, the singer founded the Delta Goodrem Foundation, which has raised over $120 million for blood cancer research. Speaking to Mail columnist Bryony Gordon, Delta recounted the two greatest health challenges of her life: the early cancer diagnosis and the 'game-changing' moment she lost her voice after having an operation on her throat. 'It was incredible', Delta began. 'My album was taking off – I was coming over to the UK to do Top of the Pops and then I found a lump in my neck. 'I was getting tired all the time and I felt my immune system was kind of breaking down. I thought that maybe I wasn't looking after myself enough – I was doing 14-hour signings. 'I was due to fly to the US, but I had a strange feeling. I had some biopsies done – and I was then diagnosed, at the same time that the world had just taken my music in. 'It changed the trajectory of my life completely. The whole country was sitting outside my front door watching me and my family go through this thing the best we could. 'I knew everything was going to be very different. How do you all of a sudden go from planes, trains, and automobiles to this being your life?' Though the diagnosis 'hurt' physically and emotionally, Delta doesn't view that period negatively because of the 'triumph' of her foundation's work. 'I don't see the cancer as dark, I see it as a triumph', she said. Years after recovering from one major career setback, Delta suffered another in 2018, having to undergo an operation that forced her to relearn how to speak 'Ever since my diagnosis, we have raised a lot of money. I have been ride or die with those people that saved me for many years now. 'I cannot look at that as dark. I look at it like – life made sure I could be of service to people.' Years after recovering from one major career setback, Delta suffered another in 2018, having to undergo an operation that forced her to relearn how to speak. A buildup of calcium in her salivary gland formed a small stone which later became lodged in her throat. 'That was a very surrendering moment', she explained. 'Everything was kind of washed off the bone. I was so glad that was private – because I needed some time. I lived out of the city in my family home - and my beautiful partner was with me. 'It was game-changing actually – having a moment to get away from all the noise.' Delta Goodrem's memoir, Bridge Over Troubled Dreams, is out now.

How Finance Minister Dominic LeBlanc's life was saved by a 20-year-old German college student
How Finance Minister Dominic LeBlanc's life was saved by a 20-year-old German college student

National Post

time26-05-2025

  • Health
  • National Post

How Finance Minister Dominic LeBlanc's life was saved by a 20-year-old German college student

Article content As the minister responsible for Canada-U.S. Trade, intergovernmental affairs and Prime Minister Mark Carney's 'One Canadian Economy' portfolio, Dominic LeBlanc will face many obstacles in the days and weeks ahead. Article content Article content But the veteran Liberal minister is no stranger to a challenge, having overcome a rare form of non-Hodgkin's lymphoma more than five years ago thanks to a stem cell donation from Germany. Article content Article content 'Two years ago, Jonathan, the brave young man who saved my life, welcomed Jolene (Richard) and me to his family's home town in Germany, Bad Hersefeld,' he posted along with two photos of himself and his wife with the now 26-year-old and his family members. Article content 'I will cherish this moment and remember his kindness, and that of his family, forever.' Article content Article content Article content In April 2019, while overseeing intergovernmental affairs, northern affairs and internal trade under then-prime minister Justin Trudeau, a 51-year-old LeBlanc, feeling particularly unwell, was informed by Moncton doctors he had a 'lethal form' of non-Hodgkin's lymphoma. Article content His only chance at survival: 'very aggressive' chemotherapies and a stem cell donation via an allogeneic transplant — obtaining healthy stem cells from a donor who is not identical to the recipient. Article content In an interview with DKMS, the German-based international blood science organization that ultimately paired him with Kehl, LeBlanc said it took doctors a few weeks to figure out the 'right recipe of chemotherapy' to get his cancer into remission before referring him to Montreal's Maisonneuve-Rosemont Hospital, a facility renowned for its expertise in hematology and stem cell transplants.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store